<pmc-articleset>
  <article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4">
    <!--The publisher of this article does not allow downloading of the full text in XML form.-->
    <front>
      <journal-meta>
        <journal-id journal-id-type="nlm-ta">J Clin Invest</journal-id>
        <journal-id journal-id-type="iso-abbrev">J. Clin. Invest</journal-id>
        <journal-id journal-id-type="pmc-domain-id">120</journal-id>
        <journal-id journal-id-type="pmc-domain">jcinvest</journal-id>
        <journal-id journal-id-type="publisher-id">J Clin Invest</journal-id>
        <journal-title-group>
          <journal-title>The Journal of Clinical Investigation</journal-title>
        </journal-title-group>
        <issn pub-type="ppub">0021-9738</issn>
        <issn pub-type="epub">1558-8238</issn>
        <publisher>
          <publisher-name>American Society for Clinical Investigation</publisher-name>
        </publisher>
      </journal-meta>
      <article-meta>
        <article-id pub-id-type="pmcid">PMC4767360</article-id>
        <article-id pub-id-type="pmcid-ver">PMC4767360.1</article-id>
        <article-id pub-id-type="pmcaid">4767360</article-id>
        <article-id pub-id-type="pmcaiid">4767360</article-id>
        <article-id pub-id-type="pmid">26878173</article-id>
        <article-id pub-id-type="doi">10.1172/JCI85271</article-id>
        <article-id pub-id-type="publisher-id">85271</article-id>
        <article-version article-version-type="pmc-version">1</article-version>
        <article-categories>
          <subj-group subj-group-type="heading">
            <subject>Clinical Medicine</subject>
          </subj-group>
        </article-categories>
        <title-group>
          <article-title>Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers</article-title>
        </title-group>
        <contrib-group>
          <contrib contrib-type="author" corresp="yes">
            <name name-style="western">
              <surname>Landa</surname>
              <given-names initials="I">Iñigo</given-names>
            </name>
            <email>landaloi@mskcc.org</email>
            <xref ref-type="aff" rid="A1">1</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Ibrahimpasic</surname>
              <given-names initials="T">Tihana</given-names>
            </name>
            <email>tihana_i@yahoo.co.uk</email>
            <xref ref-type="aff" rid="A2">2</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Boucai</surname>
              <given-names initials="L">Laura</given-names>
            </name>
            <email>boucail@mskcc.org</email>
            <xref ref-type="aff" rid="A3">3</xref>
          </contrib>
          <contrib contrib-type="author">
            <contrib-id contrib-id-type="orcid" authenticated="true">http://orcid.org/0000-0001-5497-5055</contrib-id>
            <name name-style="western">
              <surname>Sinha</surname>
              <given-names initials="R">Rileen</given-names>
            </name>
            <email>rileen@gmail.com</email>
            <xref ref-type="aff" rid="A4">4</xref>
            <xref ref-type="aff" rid="A5">5</xref>
          </contrib>
          <contrib contrib-type="author">
            <contrib-id contrib-id-type="orcid" authenticated="true">http://orcid.org/0000-0003-4456-8792</contrib-id>
            <name name-style="western">
              <surname>Knauf</surname>
              <given-names initials="JA">Jeffrey A.</given-names>
            </name>
            <email>Knaufj@mskcc.org</email>
            <xref ref-type="aff" rid="A1">1</xref>
            <xref ref-type="aff" rid="A3">3</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Shah</surname>
              <given-names initials="RH">Ronak H.</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Dogan</surname>
              <given-names initials="S">Snjezana</given-names>
            </name>
            <email>dogans@mskcc.org</email>
            <xref ref-type="aff" rid="A6">6</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Ricarte-Filho</surname>
              <given-names initials="JC">Julio C.</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Krishnamoorthy</surname>
              <given-names initials="GP">Gnana P.</given-names>
            </name>
            <email>krishnag@mskcc.org</email>
            <xref ref-type="aff" rid="A1">1</xref>
          </contrib>
          <contrib contrib-type="author">
            <contrib-id contrib-id-type="orcid" authenticated="true">http://orcid.org/0000-0003-4638-9835</contrib-id>
            <name name-style="western">
              <surname>Xu</surname>
              <given-names initials="B">Bin</given-names>
            </name>
            <email>xub@mskcc.org</email>
            <xref ref-type="aff" rid="A6">6</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Schultz</surname>
              <given-names initials="N">Nikolaus</given-names>
            </name>
            <email>schultzn@mskcc.org</email>
            <xref ref-type="aff" rid="A7">7</xref>
            <xref ref-type="aff" rid="A8">8</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Berger</surname>
              <given-names initials="MF">Michael F.</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
            <xref ref-type="aff" rid="A6">6</xref>
            <xref ref-type="aff" rid="A8">8</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Sander</surname>
              <given-names initials="C">Chris</given-names>
            </name>
            <email>chris@sanderlab.org</email>
            <xref ref-type="aff" rid="A4">4</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Taylor</surname>
              <given-names initials="BS">Barry S.</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
            <xref ref-type="aff" rid="A7">7</xref>
            <xref ref-type="aff" rid="A8">8</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Ghossein</surname>
              <given-names initials="R">Ronald</given-names>
            </name>
            <email>ghosseir@mskcc.org</email>
            <xref ref-type="aff" rid="A6">6</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Ganly</surname>
              <given-names initials="I">Ian</given-names>
            </name>
            <email>ganlyi@mskcc.org</email>
            <xref ref-type="aff" rid="A1">1</xref>
            <xref ref-type="aff" rid="A2">2</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Fagin</surname>
              <given-names initials="JA">James A.</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
            <xref ref-type="aff" rid="A3">3</xref>
          </contrib>
        </contrib-group>
        <aff id="A1"><label>1</label>Human Oncology and Pathogenesis Program,</aff>
        <aff id="A2"><label>2</label>Department of Surgery,</aff>
        <aff id="A3"><label>3</label>Department of Medicine, and</aff>
        <aff id="A4"><label>4</label>Computational Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA.</aff>
        <aff id="A5"><label>5</label>Department of Genetics and Genomic Sciences, Icahn Institute of Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.</aff>
        <aff id="A6"><label>6</label>Department of Pathology,</aff>
        <aff id="A7"><label>7</label>Department of Epidemiology and Biostatistics, and</aff>
        <aff id="A8"><label>8</label>Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.</aff>
        <author-notes>
          <corresp>Address correspondence to: James A. Fagin, Department of Medicine and Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, Box 296, New York, New York 10065, USA. Phone: 646.888.2136; E-mail: <email>faginj@mskcc.org</email>. Or to: Ian Ganly, Department of Surgery and Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, Box 296, New York, New York 10065, USA. Phone: 212.639.6244; E-mail: <email>ganlyi@mskcc.org</email>.</corresp>
          <fn>
            <p><bold>Authorship note:</bold> I. Landa and T. Ibrahimpasic contributed equally to this work.</p>
          </fn>
        </author-notes>
        <pub-date date-type="pub" publication-format="electronic" iso-8601-date="2016-02-15">
          <day>15</day>
          <month>2</month>
          <year>2016</year>
        </pub-date>
        <pub-date date-type="pub" publication-format="print" iso-8601-date="2016-03-01">
          <day>1</day>
          <month>3</month>
          <year>2016</year>
        </pub-date>
        <volume>126</volume>
        <issue>3</issue>
        <issue-id pub-id-type="pmc-issue-id">265786</issue-id>
        <fpage>1052</fpage>
        <lpage>1066</lpage>
        <history>
          <date date-type="received">
            <day>27</day>
            <month>10</month>
            <year>2015</year>
          </date>
          <date date-type="accepted">
            <day>4</day>
            <month>1</month>
            <year>2016</year>
          </date>
        </history>
        <pub-history>
          <event event-type="pmc-release">
            <date>
              <day>01</day>
              <month>06</month>
              <year>2016</year>
            </date>
          </event>
          <event event-type="pmc-live">
            <date>
              <day>01</day>
              <month>06</month>
              <year>2016</year>
            </date>
          </event>
          <event event-type="pmc-last-change">
            <date iso-8601-date="2024-07-10 02:25:14.807">
              <day>10</day>
              <month>07</month>
              <year>2024</year>
            </date>
          </event>
        </pub-history>
        <permissions>
          <copyright-statement>Copyright © 2016, American Society for Clinical Investigation</copyright-statement>
          <copyright-year>2016</copyright-year>
          <copyright-holder>American Society for Clinical Investigation</copyright-holder>
        </permissions>
        <self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="JCI85271.pdf"/>
        <self-uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.jci.org/articles/view/85271">This article is available online at https://www.jci.org/articles/view/85271</self-uri>
        <abstract>
          <p><bold>BACKGROUND.</bold> Poorly differentiated thyroid cancer (PDTC) and anaplastic thyroid cancer (ATC) are rare and frequently lethal tumors that so far have not been subjected to comprehensive genetic characterization.</p>
          <p><bold>METHODS.</bold> We performed next-generation sequencing of 341 cancer genes from 117 patient-derived PDTCs and ATCs and analyzed the transcriptome of a representative subset of 37 tumors. Results were analyzed in the context of The Cancer Genome Atlas study (TCGA study) of papillary thyroid cancers (PTC).</p>
          <p><bold>RESULTS.</bold> Compared to PDTCs, ATCs had a greater mutation burden, including a higher frequency of mutations in <italic toggle="yes">TP53</italic>, <italic toggle="yes">TERT</italic> promoter, PI3K/AKT/mTOR pathway effectors, SWI/SNF subunits, and histone methyltransferases. <italic toggle="yes">BRAF</italic> and <italic toggle="yes">RAS</italic> were the predominant drivers and dictated distinct tropism for nodal versus distant metastases in PDTC. <italic toggle="yes">RAS</italic> and <italic toggle="yes">BRAF</italic> sharply distinguished between PDTCs defined by the Turin (PDTC-Turin) versus MSKCC (PDTC-MSK) criteria, respectively. Mutations of <italic toggle="yes">EIF1AX</italic>, a component of the translational preinitiation complex, were markedly enriched in PDTCs and ATCs and had a striking pattern of co-occurrence with <italic toggle="yes">RAS</italic> mutations. While <italic toggle="yes">TERT</italic> promoter mutations were rare and subclonal in PTCs, they were clonal and highly prevalent in advanced cancers. Application of the TCGA-derived BRAF-RAS score (a measure of MAPK transcriptional output) revealed a preserved relationship with <italic toggle="yes">BRAF</italic>/<italic toggle="yes">RAS</italic> mutation in PDTCs, whereas ATCs were <italic toggle="yes">BRAF</italic>-like irrespective of driver mutation.</p>
          <p><bold>CONCLUSIONS.</bold> These data support a model of tumorigenesis whereby PDTCs and ATCs arise from well-differentiated tumors through the accumulation of key additional genetic abnormalities, many of which have prognostic and possible therapeutic relevance. The widespread genomic disruptions in ATC compared with PDTC underscore their greater virulence and higher mortality.</p>
          <p><bold>FUNDING.</bold> This work was supported in part by NIH grants CA50706, CA72597, P50-CA72012, P30-CA008748, and 5T32-<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="CA160001">CA160001</ext-link>; the Lefkovsky Family Foundation; the Society of Memorial Sloan Kettering; the Byrne fund; and Cycle for Survival.</p>
        </abstract>
        <custom-meta-group>
          <custom-meta>
            <meta-name>pmc-status-qastatus</meta-name>
            <meta-value>0</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-status-live</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-status-embargo</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-status-released</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-open-access</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-olf</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-manuscript</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-legally-suppressed</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-has-pdf</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-has-supplement</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-pdf-only</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-suppress-copyright</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-is-real-version</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-is-scanned-article</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-preprint</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-in-epmc</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
        </custom-meta-group>
      </article-meta>
    </front>
  </article>
</pmc-articleset>
